For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

The Global Coalition on Aging (GCOA) last week issued a report calling on G7 countries to commit to funding pull incentives and making other investments in antibiotic innovation.

Common infections will kill millions if drug resistance through misuse of antibiotics is not curbed, says England’s ex-chief medical officer.

It kills millions every year, with a potential impact in the near future that could dwarf that of the Covid-19 pandemic but AMR, or antimicrobial resistance, remains a little-known problem outside specialist circles.

Otsuka America Pharmaceutical Inc., Evelyn Y. Davis Foundation, Ralph C. Wilson, Jr. Foundation, Care.com, the National Alliance on Mental Illness, and The John A. Hartford Foundation Join in Funding Latest Project in Well Beings Health Campaign from Public Media Project Partners on National Engagement Initiative Include Rosalynn Carter Institute for Caregivers, Milken Institute Center for…